Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY: HIMS )

54.04 -12.37 (-18.63%)
Streaming Delayed Price Updated: 11:30 AM EST, Feb 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
21 22 Next >
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Peering Into Hims & Hers Health's Recent Short Interest
Via Benzinga
3 Stocks That Can Double Again in 2024
It wasn't easy to double in 2024, but these three stocks made it happen. They might be able to do it again. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Is Hims & Hers Stock a Buy After Short Report?
There are valid points in the short report, but it may present a buying opportunity for long-term investors. 
Via The Motley Fool
Hims & Hers Stock Drops 12.8% After Short Report
Is this a warning or a buy sign for Hims & Hers stock? 
Via The Motley Fool
Market Whales and Their Recent Bets on HIMS Options
Via Benzinga
8 Analysts Assess Hims & Hers Health: What You Need To Know
Via Benzinga
Looking Into Hims & Hers Health's Recent Short Interest
Via Benzinga
Phunware (PHUN) Stock Volatile Ahead of Trump-Biden Debate Tonight
Phunware stock is on the move Thursday as investors in PHUN shares prepare for Donald Trump to debate Joe Biden tonight. 
Via InvestorPlace
Topics Government
Exposures Political
Walgreens Stores Closing: Retailer Announces ‘Imminent’ Changes as WBA Stock Slumps
Walgreens stores will be closing as the company's CEO announces that changes need to happen at the struggling pharmacy chain. 
Via InvestorPlace
Hims & Hers Health Stock Is Sliding Thursday: What's Going On?
Hunterbrook releases a bearish report alleging that Hims & Hers sells knockoff GLP-1 weight loss drugs and relies on a single supplier with previously unreported ties to fraud and bankruptcy. 
Via Benzinga
Topics Fraud Supply Chain
Exposures Legal Supply Chain
Short Seller Hunterbrook Slams Hims & Hers (HIMS) Stock in New Report
HIMS stock is trading lower after Hunterbrook Media published a short report on the company, taking issue with its compounded GLP-1 drug. 
Via InvestorPlace
Levi Strauss Posts Mixed Results, Joins Walgreens, AeroVironment And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
2 Top Growth Stocks to Buy With $500 Right Now
These top stocks have roaring growth stories to follow. 
Via The Motley Fool
Why Hims Is a 10x Stock
Disrupting the medical industry has enormous upside. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Should You Buy Hims & Hers Health Stock Right Now?
The telehealth company is offering innovative products at lower prices. 
Via The Motley Fool
Pre-Market Movers - June 21, 2024
Sarepta jumps after announcing expanded approval of DMD drug and more news on today's top movers. 
Via Talk Markets
Eli Lilly's Stock Surge Driven by GLP-1 Demand
Shares of Eli Lilly stock are about to hit a new all-time high, sponsored by the pending approval of new weight loss drugs 
Via MarketBeat
Topics Economy
Exposures Interest Rates
Avidity Biosciences And CleanSpark Were Among The 10 Biggest Mid-Cap Stock Gainers Last Week (June 9-June 15): Are These In Your Portfolio?
Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, CleanSpark, Enovix Corp, Axcelis Tech, Intellia Therapeutics, Korn Ferry. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Chart Of The Day: Hims & Hers Health - Good Growth In Good Sex
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. 
Via Talk Markets
3 Sector Stars Lead Growth: Foot Locker, Shake Shack, Hims & Hers
These three stocks are looking to get a chunk of the total added jobs in the economy, meaning that analyst double-digit upside and growth projections are real 
Via MarketBeat
Topics Economy
Exposures Economy
MarketBeat Week in Review – 6/3 - 6/7
Equity markets shrugged off a much hotter-than-expected jobs report, but there could be more volatility after the next readings on inflation come out next week 
Via MarketBeat
Topics Economy
Exposures Interest Rates
EXCLUSIVE: Top 10 Most Searched Tickers On Benzinga Pro In May: Where Do Nvidia, Tesla, GameStop, AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Kimberly-Clark To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
Hims & Hers Health Soars on Generic GLP-1 Rollout Plans
Him & Hers Health Inc. (NYSE: HIMS) provides a direct-to-consumer (DTC) health and wellness platform. The company was best known for prescribing treatments 
Via MarketBeat
Hims & Hers Health Stock Soared This Week: Here's Why
The company is still riding momentum from its recent weight loss drug announcement. 
Via The Motley Fool
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
21 22 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.